<> <http://www.w3.org/2000/01/rdf-schema#comment> "The repository administrator has not yet configured an RDF license."^^<http://www.w3.org/2001/XMLSchema#string> .
<> <http://xmlns.com/foaf/0.1/primaryTopic> <https://arxiv.universalpublishings.com/id/eprint/96376> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/AcademicArticle> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Article> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://purl.org/dc/terms/title> "IMPACT OF ANTICOAGULANT THERAPY ON HEMOSTATIC AND INFLAMMATORY MARKERS IN PATIENTS WITH IMMUNE-MEDIATED MICROVASCULAR THROMBOSIS"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://purl.org/ontology/bibo/abstract> "Immune-mediated microvascular thrombosis (IMMT) is a complex disorder driven by immune dysregulation, leading to microvascular occlusion and necessitating anticoagulant therapy. This study evaluates the impact of anticoagulant therapy on hemostatic parameters (D-dimer, fibrinogen, prothrombin time [PT], activated partial thromboplastin time [APTT]) and inflammatory markers (C-reactive protein [CRP], interleukin-6 [IL-6]) in 45 patients with IMMT. Patients were followed for 12 months, receiving either warfarin or direct oral anticoagulants (DOACs). D-dimer levels decreased significantly (1.5 µg/mL to 0.6 µg/mL, p&lt;0.01), with DOACs showing greater reduction (p=0.02). Fibrinogen remained elevated in 60% of patients (mean 4.3 ± 0.9 g/L), correlating with CRP (r=0.65, p&lt;0.01). IL-6 levels declined from 12.5 pg/mL to 5.8 pg/mL (p&lt;0.05), reflecting reduced inflammation. Thrombotic recurrence occurred in 18% of patients, associated with persistent fibrinogen elevation (OR 2.9, 95% CI 1.1–7.6, p=0.03). These findings highlight the role of hemostatic and inflammatory markers in monitoring therapy efficacy and predicting outcomes in IMMT, supporting personalized treatment approaches."^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://purl.org/dc/terms/date> "2025-05-17" .
<https://arxiv.universalpublishings.com/id/document/18001> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Document> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://purl.org/ontology/bibo/volume> "2" .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://purl.org/ontology/bibo/issue> "5" .
<https://arxiv.universalpublishings.com/id/publication/ext-546e52ae7c506fc5aad4ed9f115c9825> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Collection> .
<https://arxiv.universalpublishings.com/id/publication/ext-546e52ae7c506fc5aad4ed9f115c9825> <http://xmlns.com/foaf/0.1/name> "CONFERENCE ON THE ROLE AND IMPORTANCE OF SCIENCE IN THE MODERN WORLD"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://purl.org/dc/terms/isPartOf> <https://arxiv.universalpublishings.com/id/publication/ext-546e52ae7c506fc5aad4ed9f115c9825> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://purl.org/ontology/bibo/status> <http://purl.org/ontology/bibo/status/published> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://purl.org/dc/terms/creator> <https://arxiv.universalpublishings.com/id/person/ext-0cd4fd7bdcff643e66716fe55be41252> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://purl.org/ontology/bibo/authorList> <https://arxiv.universalpublishings.com/id/eprint/96376#authors> .
<https://arxiv.universalpublishings.com/id/eprint/96376#authors> <http://www.w3.org/1999/02/22-rdf-syntax-ns#_1> <https://arxiv.universalpublishings.com/id/person/ext-0cd4fd7bdcff643e66716fe55be41252> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://purl.org/dc/terms/creator> <https://arxiv.universalpublishings.com/id/person/ext-e5649e71cca6f214774d012cf6f9d21c> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://purl.org/ontology/bibo/authorList> <https://arxiv.universalpublishings.com/id/eprint/96376#authors> .
<https://arxiv.universalpublishings.com/id/eprint/96376#authors> <http://www.w3.org/1999/02/22-rdf-syntax-ns#_2> <https://arxiv.universalpublishings.com/id/person/ext-e5649e71cca6f214774d012cf6f9d21c> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://purl.org/dc/terms/creator> <https://arxiv.universalpublishings.com/id/person/ext-20ad5bd474ae485296f632e2a4745421> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://purl.org/ontology/bibo/authorList> <https://arxiv.universalpublishings.com/id/eprint/96376#authors> .
<https://arxiv.universalpublishings.com/id/eprint/96376#authors> <http://www.w3.org/1999/02/22-rdf-syntax-ns#_3> <https://arxiv.universalpublishings.com/id/person/ext-20ad5bd474ae485296f632e2a4745421> .
<https://arxiv.universalpublishings.com/id/person/ext-e5649e71cca6f214774d012cf6f9d21c> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://arxiv.universalpublishings.com/id/person/ext-e5649e71cca6f214774d012cf6f9d21c> <http://xmlns.com/foaf/0.1/givenName> "S.A"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-e5649e71cca6f214774d012cf6f9d21c> <http://xmlns.com/foaf/0.1/familyName> "Babadjanov"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-e5649e71cca6f214774d012cf6f9d21c> <http://xmlns.com/foaf/0.1/name> "S.A Babadjanov"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-20ad5bd474ae485296f632e2a4745421> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://arxiv.universalpublishings.com/id/person/ext-20ad5bd474ae485296f632e2a4745421> <http://xmlns.com/foaf/0.1/givenName> "U.A"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-20ad5bd474ae485296f632e2a4745421> <http://xmlns.com/foaf/0.1/familyName> "Begmatova"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-20ad5bd474ae485296f632e2a4745421> <http://xmlns.com/foaf/0.1/name> "U.A Begmatova"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-0cd4fd7bdcff643e66716fe55be41252> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://arxiv.universalpublishings.com/id/person/ext-0cd4fd7bdcff643e66716fe55be41252> <http://xmlns.com/foaf/0.1/givenName> "Z.Ch"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-0cd4fd7bdcff643e66716fe55be41252> <http://xmlns.com/foaf/0.1/familyName> "Kurbanova"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-0cd4fd7bdcff643e66716fe55be41252> <http://xmlns.com/foaf/0.1/name> "Z.Ch Kurbanova"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://eprints.org/ontology/EPrint> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://eprints.org/ontology/ArticleEPrint> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://purl.org/dc/terms/isPartOf> <https://arxiv.universalpublishings.com/id/repository> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://eprints.org/ontology/hasDocument> <https://arxiv.universalpublishings.com/id/document/18001> .
<https://arxiv.universalpublishings.com/id/document/18001> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://eprints.org/ontology/Document> .
<https://arxiv.universalpublishings.com/id/document/18001> <http://www.w3.org/2000/01/rdf-schema#label> "IMPACT OF ANTICOAGULANT THERAPY ON HEMOSTATIC AND INFLAMMATORY MARKERS IN PATIENTS WITH IMMUNE-MEDIATED MICROVASCULAR THROMBOSIS (PDF)"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://purl.org/dc/elements/1.1/hasVersion> <https://arxiv.universalpublishings.com/id/document/18001> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://eprints.org/ontology/hasPublished> <https://arxiv.universalpublishings.com/id/document/18001> .
<https://arxiv.universalpublishings.com/id/document/18001> <http://eprints.org/ontology/hasFile> <https://arxiv.universalpublishings.com/id/eprint/96376/1/137-142.pdf> .
<https://arxiv.universalpublishings.com/id/document/18001> <http://purl.org/dc/terms/hasPart> <https://arxiv.universalpublishings.com/id/eprint/96376/1/137-142.pdf> .
<https://arxiv.universalpublishings.com/id/eprint/96376/1/137-142.pdf> <http://www.w3.org/2000/01/rdf-schema#label> "137-142.pdf"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/96376> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <https://arxiv.universalpublishings.com/id/eprint/96376/> .
<https://arxiv.universalpublishings.com/id/eprint/96376/> <http://purl.org/dc/elements/1.1/title> "HTML Summary of #96376 \n\nIMPACT OF ANTICOAGULANT THERAPY ON HEMOSTATIC AND INFLAMMATORY MARKERS IN PATIENTS WITH IMMUNE-MEDIATED MICROVASCULAR THROMBOSIS\n\n" .
<https://arxiv.universalpublishings.com/id/eprint/96376/> <http://purl.org/dc/elements/1.1/format> "text/html" .
<https://arxiv.universalpublishings.com/id/eprint/96376/> <http://xmlns.com/foaf/0.1/primaryTopic> <https://arxiv.universalpublishings.com/id/eprint/96376> .